231 related articles for article (PubMed ID: 35179996)
1. Research Progress of Exosome-Loaded miRNA in Osteosarcoma.
Yao P; Lu Y; Cai Z; Yu T; Kang Y; Zhang Y; Wang X
Cancer Control; 2022; 29():10732748221076683. PubMed ID: 35179996
[TBL] [Abstract][Full Text] [Related]
2. The promising roles of exosomal microRNAs in osteosarcoma: A new insight into the clinical therapy.
Tian W; Niu X; Feng F; Wang X; Wang J; Yao W; Zhang P
Biomed Pharmacother; 2023 Jul; 163():114771. PubMed ID: 37119740
[TBL] [Abstract][Full Text] [Related]
3. Transfer of exosomal microRNAs confers doxorubicin resistance in osteosarcoma cells.
Cai T; Zhang C; Zhan T
Mol Med Rep; 2023 Apr; 27(4):. PubMed ID: 36866739
[TBL] [Abstract][Full Text] [Related]
4. Role of exosomal miR‑21 in the tumor microenvironment and osteosarcoma tumorigenesis and progression (Review).
Wang S; Ma F; Feng Y; Liu T; He S
Int J Oncol; 2020 May; 56(5):1055-1063. PubMed ID: 32319566
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
[TBL] [Abstract][Full Text] [Related]
6. Exosomal miR-1228 From Cancer-Associated Fibroblasts Promotes Cell Migration and Invasion of Osteosarcoma by Directly Targeting SCAI.
Wang JW; Wu XF; Gu XJ; Jiang XH
Oncol Res; 2019 Sep; 27(9):979-986. PubMed ID: 30180920
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects.
Miao J; Wu S; Peng Z; Tania M; Zhang C
Tumour Biol; 2013 Aug; 34(4):2093-8. PubMed ID: 23797816
[TBL] [Abstract][Full Text] [Related]
8. Role of miRNA-542-5p in the tumorigenesis of osteosarcoma.
Zhu T; Fan D; Ye K; Liu B; Cui Z; Liu Z; Tian Y
FEBS Open Bio; 2020 Apr; 10(4):627-636. PubMed ID: 32105410
[TBL] [Abstract][Full Text] [Related]
9. Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma.
Tang Z; Lu Y; Chen Y; Zhang J; Chen Z; Wang Q
Technol Cancer Res Treat; 2021; 20():15330338211034262. PubMed ID: 34323141
[TBL] [Abstract][Full Text] [Related]
10. An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.
Hill KE; Kelly AD; Kuijjer ML; Barry W; Rattani A; Garbutt CC; Kissick H; Janeway K; Perez-Atayde A; Goldsmith J; Gebhardt MC; Arredouani MS; Cote G; Hornicek F; Choy E; Duan Z; Quackenbush J; Haibe-Kains B; Spentzos D
J Hematol Oncol; 2017 May; 10(1):107. PubMed ID: 28506242
[TBL] [Abstract][Full Text] [Related]
11. Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy.
Chen D; Liu D; Chen Z
Tumour Biol; 2017 Sep; 39(9):1010428317705762. PubMed ID: 28933259
[TBL] [Abstract][Full Text] [Related]
12. Osteosarcoma cell-derived exosomes affect tumor microenvironment by specific packaging of microRNAs.
Raimondi L; De Luca A; Gallo A; Costa V; Russelli G; Cuscino N; Manno M; Raccosta S; Carina V; Bellavia D; Conigliaro A; Alessandro R; Fini M; Conaldi PG; Giavaresi G
Carcinogenesis; 2020 Jul; 41(5):666-677. PubMed ID: 31294446
[TBL] [Abstract][Full Text] [Related]
13. Engineered exosome as targeted lncRNA MEG3 delivery vehicles for osteosarcoma therapy.
Huang X; Wu W; Jing D; Yang L; Guo H; Wang L; Zhang W; Pu F; Shao Z
J Control Release; 2022 Mar; 343():107-117. PubMed ID: 35077741
[TBL] [Abstract][Full Text] [Related]
14. Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response.
Gougelet A; Pissaloux D; Besse A; Perez J; Duc A; Dutour A; Blay JY; Alberti L
Int J Cancer; 2011 Aug; 129(3):680-90. PubMed ID: 20949564
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
Liu W; Zhao X; Zhang YJ; Fang GW; Xue Y
J Int Med Res; 2018 Mar; 46(3):975-983. PubMed ID: 29115164
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressing role of serum-derived exosomal microRNA-15a in osteosarcoma cells through the GATA binding protein 2/murine double minute 2 axis and the p53 signaling pathway.
Wu C; Li Z; Feng G; Wang L; Xie J; Jin Y; Wang L; Liu S
Bioengineered; 2021 Dec; 12(1):8378-8395. PubMed ID: 34592889
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow-derived mesenchymal stem cell-derived exosomal microRNA-208a promotes osteosarcoma cell proliferation, migration, and invasion.
Qin F; Tang H; Zhang Y; Zhang Z; Huang P; Zhu J
J Cell Physiol; 2020 May; 235(5):4734-4745. PubMed ID: 31637737
[TBL] [Abstract][Full Text] [Related]
18. Exosomes and osteosarcoma drug resistance.
Fu H; Wu Y; Chen J; Hu X; Wang X; Xu G
Front Oncol; 2023; 13():1133726. PubMed ID: 37007086
[TBL] [Abstract][Full Text] [Related]
19. Review of microRNA in osteosarcoma and chondrosarcoma.
Chang L; Shrestha S; LaChaud G; Scott MA; James AW
Med Oncol; 2015 Jun; 32(6):613. PubMed ID: 25920607
[TBL] [Abstract][Full Text] [Related]
20. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
